萬科A(000002.SZ):萬物雲向香港聯交所提交上市申請
格隆匯4月1日丨萬科A(000002.SZ)公佈,公司獲知,萬物雲於2022年3月31日通過其聯席保薦人向香港聯交所呈交上市申請(A1表格),以申請萬物雲的股份於香港聯交所主板上市及批準買賣。萬物雲上市文件申請版本的編纂版本於香港聯交所網站可供查閱及下載。
申請版本載有(其中包括)有關萬物雲的若幹業務及財務資料。公司股東及潛在投資者務請注意,申請版本爲草擬稿,其中所載資料可能會有重大改動。公司不就申請版本的內容承擔任何義務或責任。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.